Schedule 13D ownership disclosure

Elicio Therapeutics, Inc.

Security class unavailable · CUSIP: 28657F103

Event date: 2023-06-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
707,164
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001068238-23-000119
Form type
SC 13D
Filer
Elicio Therapeutics, Inc.
CIK
CIK 1601485
Filed
Jun 14, 2023
Reporting period
Jun 01, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub